Effect of atorvastatin on the cortical bones of corticosteroid treated rabbits

Journal of Orthopaedic Research

Volumn 30, Issue 6, 2012, Pages 872-876

  Handal, John A ^a   John, Thomas K ^a   Goldstein, Daniel T ^a   Khurana, Jasvir S ^b   Saing, Minn ^a   Braitman, Leonard E ^a   Samuel, Solomon P ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Atorvastatin calcium; Corticosteroid; Flexural strength; Osteoporosis; Statin

Indexed keywords

ATORVASTATIN; METHYLPREDNISOLONE ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE STRENGTH; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RABBIT; TREATMENT OUTCOME;

ANIMALS; ANTICHOLESTEREMIC AGENTS; COMPRESSIVE STRENGTH; DRUG INTERACTIONS; EQUIPMENT FAILURE ANALYSIS; FEMUR; GLUCOCORTICOIDS; HEPTANOIC ACIDS; INJECTIONS, INTRAMUSCULAR; METHYLPREDNISOLONE; PYRROLES; RABBITS; STRESS, MECHANICAL; TIBIA;

EID: 84859629111     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22030     Document Type: Article

References (26)

1. Wei L, MacDonald TM, Walker BR. 2004. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764-770.
2. Walker BR. 2007. Glucocorticoids cardiovascular disease. Eur J Endocrinol 157:545-559.
3. Sambrook P, Birmingham J, Kelly P, et al. 1993. Prevention of corticosteroid osteoporosis - a comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328:1747-1752. (Pubitemid 23170124)
4. Lane NE, Sanchez S, Modin GW, et al. 1998. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102:1627.
5. Van Staa TP, Leufkens HGM, Abenhaim L, et al. 2000. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000. (Pubitemid 30350061)
6. Fukui K, Kominami R, Shinohara H, et al. 2006. Glucocorticoid induces micro-fat embolism in the rabbit: a scanning electron microscopic study. J Orthop Res 24:675-683. (Pubitemid 43804961)
7. Pritchett JW. 2001. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res (386):173-178. (Pubitemid 32391291)
8. Boskey AL, Raggio CL, Bullough PG, et al. 1983. Changes in the bone tissue-lipids in persons with steroid-induced and alcohol-induced osteonecrosis. Clin Orthop Relat Res (172): 289-295. (Pubitemid 13138430)
9. Vaughan CJ, Murphy MB, Buckley BM. 1996. Statins do more than just lower cholesterol. Lancet 348:1079-1082. (Pubitemid 26343606)
10. Wang GJ, Rawles JG, Hubbard SL, et al. 1983. Steroid-induced femoral-head pressure changes and their response to lipid-clearing agents. Clin Orthop Relat Res (174):298-302. (Pubitemid 13122204)
11. Belmont HM, Lydon E, Rafii M, et al. 2004. Prevention of avascular necrosis of bone in systemic lupus erythematosus: APLLE trial. Arthritis Rheum 50:S597-S598.
12. Cui QJ, Wang GJ, Su CC, et al. 1997. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res (344):8-19.
13. Lydon E, Schweitzer M, Belmont HM. 2006. Atorvostatin to prevent avascular necrosis of bone in systemic lupus erythematosus. Arthritis and Rheum 54:S432-S432.
14. Mundy G, Garrett R, Harris S, et al. 1999. Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946-1949. (Pubitemid 129515901)
15. Lee Y, Schmid MJ, Marx DB, et al. 2008. The effect of local simvastatin delivery strategies on mandibular bone formation in vivo. Biomaterials 29:1940-1949.
16. Mundy GR. 2001. Statins and their potential for osteoporosis. Bone 29:495-497. (Pubitemid 33124289)
17. Castañeda S, Calvo E, Largo R, et al. 2008. Characterization of a new experimental model of osteoporosis in rabbits. J Bone Miner Metab 26:53-59. (Pubitemid 350308010)
18. Combes S, Larzul C, Gondret F, et al. Does selection for growth rate impair bone resistance in the rabbit? Proceedings of the 8th world rabbit congress, September 2004, Puebla, Mexico.
19. Weinstein RS, Jilka RL, Almeida M, et al. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology 151:2641-2649. DOI: 10.1210/en.2009-1488.
20. Rajamannan NM, Subramaniam M, Caira F, et al. 2005. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 112:I229-I234. (Pubitemid 41266679)
21. Hjortnaes J, Butcher J, Figueiredo JL, et al. 2010. Arterial aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J 31:1975-1984.
22. Gutierrez GE, Edwards JR, Garrett IR, et al. 2008. Transdermal lovastatin enhances fracture repair in rats. J Bone Miner Res 23:1722-1730.
23. Gutierrez GE, Lalka D, Garrett IR, et al. 2006. Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporos Int 17:1033-1042. (Pubitemid 43869919)
24. Nyan M, Sato D, Kihara H, et al. 2009. Effects of the combination with [alpha]-tricalcium phosphate and simvastatin on bone regeneration. Clin Oral Implants Res 20: 280.
25. Rosenthal KL. 2004. Therapeutic contraindications in exotic pets. Elsevier. p. 44-48.
26. O'Brien CA, Jia D, Plotkin LI, et al. 2004. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835-1841. (Pubitemid 38402392)